Alpharma Articles
MNCs "approaching generics globally"
15 July 2002
Alpharma gets generic tramadol go-ahead in USA
1 July 2002
Oxxon licenses MVA tech from Alpharma
15 April 2002
Stock Commentary - New York
18 March 2002
Alpharma posts Q4 2001 net loss
18 March 2002
IVAX' paclitaxel gets ok to stay on US market
4 February 2002
Glucophage generics arrive on US market
4 February 2002
Teva not buying Faulding injectibles
16 November 2001
Fire at Alpharma site kills one
1 October 2001
FH Faulding half-year profits up 35%
28 September 2001
Stock Commentary - New York
16 August 2001
Faulding sales rise 17.5%, boosted by pharma
9 August 2001
Stock Commentary - Tokyo
19 July 2001
Stock Commentary - New York
26 April 2001
Faulding a target for Alpharma?
12 April 2001
Stock Commentary - New York
9 November 2000
US Senate bill seeks to boost generics
15 September 2000
New European Internet exchange for generics and P-Is
21 June 2000
Schwarz profits slump in first quarter
10 May 2000
Schwarz Pharma to set up new R&D pacts
3 April 2000
Alpharma appoints CEO
13 January 2000
Munthe retires from Alpharma
30 September 1999
Schwarz posts sharp first-half profits rise
6 August 1999
Alpharma buys French generics business
21 April 1999
Stock Commentary New York
4 March 1999
Alpharma Acquire Siga Line From Hexal
7 January 1999
Hoechst Sells Cox Japan Generics Unit To Hexal
25 September 1998
Alpharma To Market First Generic Retin-A
21 May 1998
Hoechst Sells Generics Unit
7 May 1998
Indonesian Drug Industry Woes Discussed
3 April 1998
Appointment At Alpharma
5 March 1998
New York Stock Comment
3 September 1997
New York Stock Comment
10 July 1997
Alpharma To Improve Balance Sheet
2 July 1997
Interim Financial Results From The USA
18 November 1996
Alpharma Swamped By Negative Influences
18 November 1996
Assessing The Worldwide Market For Generics
28 October 1996
Teva Tempers Copaxone Profits Expectations
28 October 1996
NEW YORK STOCK COMMENT
21 October 1996
NEW YORK STOCK COMMENT
14 October 1996
Alpharma Braces Itself For Generic Industry Shift
14 October 1996
US Corporate Results Round-Up
27 May 1996
B&L Joins Legal Wrangle Over Minoxidil
6 May 1996
P&U Gets Restraining Order In Rogaine Case
22 April 1996
Generic Minoxidil Follows Hard On OTC Switch
15 April 1996
ALPharma Turns Losses Around In 1995
18 March 1996
Alpharma gets generics approval
15 January 1996
More Approvals For Alpharma Tooth Gel
4 December 1995
Alpharma sells Perio Stake
16 October 1995
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- Neovacs moving forward in rheumatoid arthritis, say analysts
